¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°ñ´Ù°øÁõÇÐȸ ±¹Á¦Çмú´ëȸ ICO2021 (3ÀÏÂ÷) : 2021-11-07

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ°ñ´Ù°øÁõÇÐȸ ±¹Á¦Çмú´ëȸ ICO2021 (3ÀÏÂ÷) : 2021-11-07
±³À°ÀÏÀÚ : 2021-11-07
±³À°Àå¼Ò : ¼­¿ïµå·¡°ï½ÃƼȣÅÚ  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà)´ëÇÑ°ñ´Ù°øÁõÇÐȸ ±¹Á¦Çмú´ëȸ ICO2021 (3ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ°ñ´Ù°øÁõÇÐȸ
´ã´çÀÚ : ¿À¼ºÈñ
¿¬¶ôó : 02-777-9896  
À̸ÞÀÏ : work@work      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤½Å°Ç°­ÀÇÇаú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаúÀÇ»çÇÐ, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥
Âü¼®¿¹»óÀοø : 80¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 12 ½Ã°£ 55ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í »çÀüµî·Ï : Àü¹®ÀÇ $100, °£È£»ç Àü°øÀÇ $50ÇöÀå µî·Ï : Àü¹®ÀÇ $120, °£È£»ç Àü°øÀÇ $70      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 09:00~09:20 Clinical implication of osteoporosis in surgical treatment of spinal disorders  Kwang-Sup Song (Korea)(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 09:20~09:40 Clinical implication of sarcopenia for spinal disorders  Hideaki Ishibashi (Japan / JOS)(INA Hospital) 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 09:40~10:00 Complicated osteoporotic spinal fractures Prevalence and its treatments  Hyoung-yeon Seo (Korea)(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 10:00~10:20 Adjuvant anti-osteoporosis treatment following hip fractures  Kee Hyung Rhyu (Korea)(°æÈñÀÇ´ë) 
Åä·Ð 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 10:20~10:35 Discussion  () 
È޽Ġ11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 10:35~10:55 Coffee Break  () 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 10:55~11:25 Treatment of high risk patients: the role of romosozumab  Felicia Cosman(Columbia University College of Physicians and Surgeons) 
Åä·Ð 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 11:25~11:35 Discussion  () 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 11:35~12:05 Role of the transforming growth factor-©¬ signaling pathway in the regulation of muscle and bone homeostasis  Se-Jin Lee( The Jackson Laboratory) 
Åä·Ð 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 12:05~12:15 Discussion  () 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 12:15~12:30 The place of denosumab in the sequential therapy of osteoporosis  Felicia Cosman(Columbia University College of Physicians and Surgeons) 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 12:30~13:15 ½Ä»ç½Ã°£  () 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 13:15~13:35 Sarcopenia: Definition and clinical impact in surgeon¡¯s perspective  Ho-Joong Kim (Korea)() 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 13:35~13:55 Pathophysiology of sarcopenia  Yuuki Imai (Japan/ JSBMR)(Ehime University) 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 13:55~14:15 Linkage between osteoporosis and sarcopenia  Young-Sang Kim (Korea)(Â÷ÀÇ´ë) 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 14:15~14:50 Promising treatment and prevention (including out-reach program)  Hiroshi Kaji (Japan / JOS)(Kindai University) 
Åä·Ð 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 14:35~14:50 Discussion  () 
È޽Ġ11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 14:50~15:10 Coffee Break  () 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 15:10~15:30 Long-term treatment strategies for postmenopausal osteoporosis  Yoo Mee Kim (Korea)(°¡Å縯°üµ¿ÀÇ´ë) 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 15:30~15:50 How to manage the rebound effect at denosumab discontinuation?  Roland Chapurlat (France / ECTS)(Hôpital E Herriot) 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 15:50~16:10 How different is the once-weekly teriparatide daily one?  Yasuhiro Takeuchi (Japan)(Toranomon Hospital) 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 16:10~16:30 PTH1 receptor signaling and therapeutic implications  Sihoon Lee (Korea)(°¡ÃµÀÇ´ë) 
Åä·Ð 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 16:30~16:45 Discussion  () 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 09:00~10:10 Oral Presentation 3  () 
Åä·Ð 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 10:10~10:35 Discussion  () 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 10:35~10:55 Coffee Break  () 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 13:15~13:35 The health impact of premature menopause including osteoporosis  Hyuntae Park (Korea)(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 13:35~13:55 Skeletal effects of hormone therapy  Unnop Jaisamram (Thailand)(Chulalongkorn University) 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 13:55~14:15 Extraskeletl effects of hormone therapy (and management of adverse effects)  Jaeyen Song(Korea)() 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 14:15~14:50 Management of osteopenia : Why? What? When?  Dongyoon Lee (Korea)(¼º±Õ°üÀÇ´ë) 
Åä·Ð 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 14:35~14:50 Discussion  () 
È޽Ġ11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 14:50~15:10 Coffee Break  () 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 15:10~15:30 Muscle mass 10 years PMO  Naohisa Miyakoshi (Japan)(Akita University Graduate School of Medicine) 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 15:30~15:50 The effect of different measurement modalities in the association oflean mass with mortality: A systematic review and meta-analysis  Gloria Hoi-Yee (Hong Kong)(The Hong Kong Polytechnic University) 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 15:50~16:10 The effectiveness of PGH  Tanawat Amphansap (Thailand)(Police General HospitalBangkok Thailand) 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 16:10~16:30 Osteopenia Osteoporosis in Malaysia  Swan Sim Yeap (Malaysia)(Subang Jaya Medical Centre) 
±³À°½Ã°£ 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 16:30~16:45 Association of height loss with falls and sarcopenia in community-dwelling older women  Ryoma Asahi (Japan)(Japan University of Health Sciences) 
Åä·Ð 11-07 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 16:45~17:00 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ±¹Á¦Çмú´ëȸ ICO2021 (3ÀÏÂ÷) : 2021-11-07""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ´ëÇÑ»êºÎÀΰú³»½Ã°æÇÐȸ Á¦31Â÷ Ãß°èÇмú´ëȸ : 2021-11-07
´ÙÀ½±Û ´ëÇÑÃÊÀ½ÆÄÀÇÇÐȸ (¿Â¶óÀÎ) Basics and Advanced Techniques for Ultrasound : 2021-11-07
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20790 °æ±â ´ëÇÑÇǺΰúÇÐȸ Á¦52Â÷ ÀÎõºÎõÁöºÎȸ ÇмúÁý´ãȸ : 2024-06-15 0 0 2024-05-27
20789 ¼­¿ï 2024³â ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ¿¬¼ö°­Á : 2024-06-15 0 2 2024-05-27
20788 Á¦ÁÖ ´ëÇѳ»ºÐºñÇÐȸ Á¦22ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-15 0 2 2024-05-27
20787 Ãæ³² (¿Â¶óÀÎ)2024³âµµ Ãæû³²µµÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-15 0 2 2024-05-27
20786 ºÎ»ê KSMO ºÎ»ê¿ï»ê°æ³²/´ë±¸°æºÏÁöȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2024-06-14 0 2 2024-05-27
20785 ¼­¿ï 2024³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (´Ù½Ã, °Ü¿ï³ª¹«¿¡¼­ º½ ³ª¹«¿¡·Î From Traditional approaches to Innovation in Psychiatry) : 2024-06-14 0 2 2024-05-27
20784 ¼­¿ï ´ëÇÑ°áÇÙÇùȸ 2024³â °áÇÙ°ü¸®±³À° 1±â(2ÀÏÂ÷) : 2024-06-14 0 3 2024-05-27
20783 ¼­¿ï Á¦14Â÷ Çѱ¹ÃÖ¼Òħ½ÀÃéÀå¼ö¼ú¿¬±¸È¸ : 2024-06-14 0 0 2024-05-27
20782 ´ëÀü 2024 Á¦40ȸ ´ëÇѼҾƿܰúÇÐȸ Ãá°èÇмú´ëȸ ¹× 40Áֳ⠱â³äÇà»ç (2ÀÏÂ÷) : 2024-06-14 0 2 2024-05-27
20781 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø RARE DISEASE SYMPOSIUM 2024 : 2024-06-14 0 0 2024-05-27
20780 ºÎ»ê 2024 ´ëÇѽŰæ¿Ü°úÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Á¦2Â÷ Á¤±âÇмú´ëȸ : 2024-06-14 0 2 2024-05-27
20779 ¼­¿ï 2024 ´ëÇÑÀÇÇÐȸ Çмú´ëȸ : 2024-06-14 0 2 2024-05-27
20778 ¼­¿ï ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-14 0 0 2024-05-27
20777 ¼­¿ï 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-14 0 2 2024-05-27
20776 ºÎ»ê 2024³â Çѱ¹°£´ãÃé¿Ü°úÇÐȸ ºÎ¿ï°æÁöȸ °£ÀÌ½Ä ½ÉÆ÷Áö¾ö : 2024-06-14 0 2 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷